ヒト成長ホルモン(hGH)の世界市場:用途別(成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他)、投与経路別(静脈内、筋肉内、皮下、経口)、流通経路別(病院薬局、小売薬局、クリニック、 オンライン薬局)

◆英語タイトル:Human Growth Hormone (hGH) Market by Application (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Small for Gestational Age, and Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Oral), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2026
◆商品コード:AMR20JN012
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2019年11月13日
◆ページ数:212
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,370 ⇒換算¥617,550見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥741,750見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥1,034,425見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートではヒト成長ホルモン(hGH)について、イントロダクション、エグゼクティブサマリー、市場概要、用途別(成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他)分析、投与経路別(静脈内、筋肉内、皮下、経口)分析、流通経路別(病院薬局、小売薬局、クリニック、 オンライン薬局)分析、地域別分析、企業概要に区分して収録しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・ヒト成長ホルモン(hGH)の世界市場:用途別(成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他)
・ヒト成長ホルモン(hGH)の世界市場:投与経路別(静脈内、筋肉内、皮下、経口)
・ヒト成長ホルモン(hGH)の世界市場:流通経路別(病院薬局、小売薬局、クリニック、 オンライン薬局)
・ヒト成長ホルモン(hGH)の世界市場:地域別
・企業概要
【レポートの概要】

The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is a protein made by the pituitary gland and is secreted into the bloodstream to other parts of the body. Its production is regulated by an intricate set of hormones produced in the hypothalamus gland, intestinal tract, and pancreas. Further, these hormones act on several tissues throughout the body. In adolescents, it stimulates the growth of bone and cartilage. Whereas in adults, it boosts protein production, promotes the utilization of fat, interferes with the action of insulin, and raises blood sugar levels. GH also raises levels of insulin-like growth factor1.

Surge in awareness regarding the effectiveness of growth hormones and increase in prevalence of chronic diseases including growth retardation and pituitary dysfunctions and surge in compliance for growth hormone formulations are the major factors that drive the growth of the global human growth hormone market. However, the side effects associated with its vigorous usage such as muscle pain, joint pain, and fluid retention and high cost of the treatment hampers the growth of the market. Moreover, stringent government approvals are expected to restrain the growth and development of the market in the coming years. Furthermore, rise in disposable income and surge in healthcare expenditure in developing economies is anticipated to create lucrative growth opportunities for the market.

The human growth hormone market can be segmented on the basis of application, route of administration, distribution channel, and region. By application, it is categorized into growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, and small for gestational age, and others . By route of administration, it is classified into intravenous, intramuscular, subcutaneous, and oral. On the basis of distribution channel, it is divided into hospital pharmacy, retail pharmacy, clinic, and online pharmacy. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
 The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
 It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
 Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
 Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS
By Application
• Growth Hormone Deficiency
• Prader-Willi Syndrome
• Turner Syndrome
• Small for Gestational Age
• Others

By Route of Administration
• Intravenous
• Intramuscular
• Subcutaneous
• Oral

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Pharmacy

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS
• Novo Nordisk
• Merck & Co., Inc
• Eli Lilly and Company
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd
• Novartis AG
• AnkeBio Co. Ltd
• F. Hoffmann-La Roche
• Ipsen
• Ferring B.V.

【レポートの目次】

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology

1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Porter’S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase In Usage Of Growth Hormone To Control Aging
3.4.1.2. Surge In Disorders Related To Growth Hormone Deficiency

3.4.2. Restraints

3.4.2.1. Side Effects Associated With The Treatment

3.4.3. Opportunities

3.4.3.1. Rise In Awareness Towards Usage Of Human Growth In Developing Economies

Chapter 4: Human Growth Hormone Market, By Application

4.1. Overview

4.1.1. Market Size And Forecast, By Application

4.2. Growth Hormone Deficiency

4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country

4.3. Prader-Willi Syndrome

4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country

4.4. Turner Syndrome

4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

4.5. Small For Gestational Age (Sga)

4.5.1. Key Market Trends And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country

4.6. Others

4.6.1. Key Market Trends And Opportunities
4.6.2. Market Size And Forecast, By Region
4.6.3. Market Analysis, By Country

Chapter 5: Human Growth Hormone Market, By Route Of Administration

5.1. Overview

5.1.1. Market Size And Forecast, By Application

5.2. Oral

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country

5.3. Intravenous

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country

5.4. Intramuscular

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country

5.5. Subcutaneous

5.5.1. Market Size And Forecast, By Region
5.5.2. Market Analysis, By Country

Chapter 6: Human Growth Hormone Market, Distribution Channel

6.1. Overview

6.1.1. Market Size And Forecast, Distribution Channel

6.2. Hospital Pharmacy

6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis, By Country

6.3. Retail Pharmacy

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country

6.4. Online Pharmacy

6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis, By Country

Chapter 7: Human Growth Hormone Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends And Opportunities
7.2.2. Market Size And Forecast, By Application
7.2.3. Market Size And Forecast, By Route Of Administration
7.2.4. Market Size And Forecast, Distribution Channel

7.2.4.1. U.S. Market Size And Forecast, By Application
7.2.4.2. U.S. Market Size And Forecast, By Route Of Administration
7.2.4.3. U.S. Market Size And Forecast, Distribution Channel
7.2.4.4. Canada Market Size And Forecast, By Application
7.2.4.5. Canada Market Size And Forecast, By Route Of Administration
7.2.4.6. Canada Market Size And Forecast, Distribution Channel
7.2.4.7. Mexico Market Size And Forecast, By Application
7.2.4.8. Mexico Market Size And Forecast, By Route Of Administration
7.2.4.9. Mexico Market Size And Forecast, Distribution Channel

7.3. Europe

7.3.1. Key Market Trends And Opportunities
7.3.2. Europe Market Size And Forecast, By Application
7.3.3. Europe Market Size And Forecast, By Route Of Administration
7.3.4. Europe Market Size And Forecast, Distribution Channel
7.3.5. Europe Market Size And Forecast, By Country

7.3.5.1. France Market Size And Forecast, By Application
7.3.5.2. France Market Size And Forecast, By Route Of Administration
7.3.5.3. France Market Size And Forecast, Distribution Channel
7.3.5.4. Uk Market Size And Forecast, By Application
7.3.5.5. Uk Market Size And Forecast, By Route Of Administration
7.3.5.6. Uk Market Size And Forecast, Distribution Channel
7.3.5.7. Germany Market Size And Forecast, By Application
7.3.5.8. Germany Market Size And Forecast, By Route Of Administration
7.3.5.9. Germany Market Size And Forecast, Distribution Channel
7.3.5.10. Spain Market Size And Forecast, By Application
7.3.5.11. Spain Market Size And Forecast, By Route Of Administration
7.3.5.12. Spain Market Size And Forecast, Distribution Channel
7.3.5.13. Rest Of Europe Market Size And Forecast, By Application
7.3.5.14. Rest Of Europe Market Size And Forecast, By Route Of Administration
7.3.5.15. Rest Of Europe Market Size And Forecast, Distribution Channel

7.4. Asia-Pacific

7.4.1. Key Market Trends And Opportunities
7.4.2. Asia-Pacific Market Size And Forecast, By Application
7.4.3. Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.4. Asia-Pacific Market Size And Forecast, Distribution Channel
7.4.5. Asia-Pacific Market Size And Forecast, By Country

7.4.5.1. Japan Market Size And Forecast, By Application
7.4.5.2. Japan Market Size And Forecast, By Route Of Administration
7.4.5.3. Japan Market Size And Forecast, Distribution Channel
7.4.5.4. China Market Size And Forecast, By Application
7.4.5.5. China Market Size And Forecast, By Route Of Administration
7.4.5.6. China Market Size And Forecast, Distribution Channel
7.4.5.7. India Market Size And Forecast, By Application
7.4.5.8. India Market Size And Forecast, By Route Of Administration
7.4.5.9. India Market Size And Forecast, Distribution Channel
7.4.5.10. Australia Market Size And Forecast, By Application
7.4.5.11. Australia Market Size And Forecast, By Application
7.4.5.12. Australia Market Size And Forecast, Distribution Channel
7.4.5.13. Rest Of Asia-Pacific Market Size And Forecast, By Application
7.4.5.14. Rest Of Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.5.15. Rest Of Asia-Pacific Market Size And Forecast, Distribution Channel

7.5. Lamea

7.5.1. Key Market Trends And Opportunities
7.5.2. Lamea Market Size And Forecast, By Application
7.5.3. Lamea Market Size And Forecast, By Route Of Administration
7.5.4. Lamea Market Size And Forecast, Distribution Channel
7.5.5. Lamea Market Size And Forecast, By Country

7.5.5.1. Brazil Market Size And Forecast, By Application
7.5.5.2. Brazil Market Size And Forecast, By Route Of Administration
7.5.5.3. Brazil Market Size And Forecast, Distribution Channel
7.5.5.4. Saudi Arabia Market Size And Forecast, By Application
7.5.5.5. Saudi Arabia Market Size And Forecast, By Route Of Administration
7.5.5.6. Saudi Arabia Market Size And Forecast, Distribution Channel
7.5.5.7. South Africa Market Size And Forecast, By Application
7.5.5.8. South Africa Market Size And Forecast, By Route Of Administration
7.5.5.9. South Africa Market Size And Forecast, Distribution Channel
7.5.5.11. Rest Of Lamea Market Size And Forecast, By Application
7.5.5.12. Rest Of Lamea Market Size And Forecast, By Route Of Administration
7.5.5.13. Rest Of Lamea Market Size And Forecast, Distribution Channel

Chapter 8: Company Profiles

8.1. Novo Nordisk

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance

8.2. Merck & Co.

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance

8.3. Eli Lilly And Company.

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance

8.4. Pfizer Inc.

8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance

8.5. Teva Pharmaceutical Industries.

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance

8.6. Novartis Ag

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance

8.7. Anhui Anke Biotechnology (Group) Co., Ltd.

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio

8.8. Roche

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance

8.9. Ipsen

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance

8.10. Ferring Bv

8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance

List of Tables

Table 01. Global Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 02. Growth Hormone Deficiency Market, By Region, 2018–2026 ($Million)
Table 03. Comparative Share Analysis of Human Growth Hormone Market For Growth Hormone Deficiency, By Country, 2018 & 2026 (%)
Table 04. Prader-Willi Syndrome Market By Region 2018–2026 ($Million)
Table 05. Comparative Share Analysis of Human Growth Hormone Market For Prader Willi, By Country, 2018 & 2026 (%)
Table 06. Turner Syndrome Market By Region 2018–2026 ($Million)
Table 07. Comparative Share Analysis of Human Growth Hormone Market For Turner Syndrome, By Country, 2018 & 2026 (%)
Table 08. Human Growth Hormone Market For Small For Gestational Age (Sga) Market By Region 2018–2026 ($Million)
Table 09. Comparative Share Analysis of Human Growth Hormone Market For Sgh, By Country, 2018 & 2026 (%)
Table 10. Human Growth Hormone Market For Other Applications By Region 2018–2026 ($Million)
Table 11. Comparative Share Analysis of Human Growth Hormone Market For Other Applications, By Country, 2018 & 2026 (%)
Table 12. Global Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 13. Oral Route of Adminstration By Region, 2018–2026 ($Million)
Table 14. Comparative Share Analysis of Human Growth Hormone Market For Oral, By Country, 2018 & 2026 (%)
Table 15. Intravenous Route of Administration Market By Region 2018–2026 ($Million)
Table 16. Comparative Share Analysis of Human Growth Hormone Market For Intravenous, By Country, 2018 & 2026 (%)
Table 17. Intramuscular Route of Administration Market By Region 2018–2026 ($Million)
Table 18. Comparative Share Analysis of Human Growth Hormone Market For Intramuscular, By Country, 2018 & 2026 (%)
Table 19. Subcutaneous Route of Administration Market By Region 2018–2026 ($Million)
Table 20. Comparative Share Analysis of Human Growth Hormone Market For Subcutaneous, By Country, 2018 & 2026 (%)
Table 21. Global Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 22. Hospital Pharmacy Human Growth Hormone Market, By Region, 2018–2026 ($Million)
Table 23. Retail Pharmacy Human Growth Hormone Market, By Region, 2018–2026 ($Million)
Table 24. Online Pharmacy Human Growth Hormone Market, By Region, 2018–2026 ($Million)
Table 25. Human Growth Hormone Market, By Region, 2018–2026 ($Million)
Table 26. North America Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 27. North America Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 28. North America Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 29. U.S. Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 30. U.S. Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 31. U.S. Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 32. Canada Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 33. Canada Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 34. Canada Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 35. Mexico Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 36. Mexico Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 37. Mexico Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 38. Europe Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 39. Europe Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 40. Europe Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 41. Europe Human Growth Hormone Market, By Country, 2018–2026 ($Million)
Table 42. France Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 43. France Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 44. France Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 45. Uk Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 46. Uk Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 47. Uk Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 48. Germany Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 49. Germany Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 50. Germany Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 51. Spain Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 52. Spain Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 53. Spain Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 54. Rest of Europe Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 55. Rest of Europe Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 56. Rest of Europe Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 57. Asia-Pacific Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 58. Asia-Pacific Human Growth Hormone Market, By Administration, 2018–2026 ($Million)
Table 59. Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 60. Asia-Pacific Human Growth Hormone Market, By Country, 2018–2026 ($Million)
Table 61. Japan Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 62. Japan Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 63. Japan Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 64. China Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 65. China Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 66. China Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 67. India Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 68. India Human Growth Hormone Market, By Administration, 2018–2026 ($Million)
Table 69. India Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 70. Australia Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 71. Australia Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 72. Australia Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 73. Rest of Asia-Pacific Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 74. Rest of Asia-Pacific Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 75. Rest of Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 76. Lamea Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 77. Lamea Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 78. Lamea Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 79. Lamea Human Growth Hormone Market, By Country, 2018–2026 ($Million)
Table 80. Brazil Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 81. Brazil Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 82. Brazil Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 83. Saudi Arabia Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 84. Saudi Arabia Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 85. Saudi Arabia Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 86. South Africa Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 87. South Africa Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 88. South Africa Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 89. Rest of Lamea Human Growth Hormone Market, By Application, 2018–2026 ($Million)
Table 90. Rest of Lamea Human Growth Hormone Market, By Route of Administration, 2018–2026 ($Million)
Table 91. Rest of Lamea Human Growth Hormone Market, Distribution Channel, 2018–2026 ($Million)
Table 92. Novo Nordisk: Company Snapshot
Table 93. Novo Nordisk: Operating Segments
Table 94. Novo Nordisk Plc: Product Portfolio
Table 95. Merck & Co.: Company Snapshot
Table 96. Merck & Co. Inc.: Operating Segments
Table 97. Merck & Co. Inc.: Product Portfolio
Table 98. Eli Lilly And Company.: Company Snapshot
Table 99. Eli Lilly And Company.: Operating Segments
Table 100. Eli Lilly And Company.: Product Portfolio:
Table 101. Pfizer Inc.: Company Snapshot
Table 102. Pfizer Inc.: Operating Segments
Table 103. Pfizer Inc.: Product Portfolio
Table 104. Teva Pharmaceutical Industries.: Company Snapshot
Table 105. Teva Pharmaceutical Industries.: Operating Segments
Table 106. Teva Pharmaceutical Industries.: Product Portfolio
Table 107. Novartis Ag: Company Snapshot
Table 108. Novartis Ag: Operating Segments
Table 109. Novartis Ag: Product Portfolio
Table 110. Anhui Anke Biotechnology (Group) Co., Ltd.: Company Snapshot
Table 111. Anhui Anke Biotechnology (Group) Co., Ltd.: Operating Segments
Table 112. Anhui Anke Biotechnology (Group) Co., Ltd: Product Portfolio
Table 113. Roche: Company Snapshot
Table 114. Roche: Operating Segments
Table 115. Roche: Product Portfolio
Table 116. Ipsen: Company Snapshot
Table 117. Ipsen: Product Segments
Table 118. Ipsen: Product Portfolio
Table 119. Ferring Bv.: Company Snapshot
Table 120. Ferring Bv.: Operating Segments
Table 121. Ferring Bv: Product Portfolio

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヒト成長ホルモン(hGH)の世界市場:用途別(成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他)、投与経路別(静脈内、筋肉内、皮下、経口)、流通経路別(病院薬局、小売薬局、クリニック、 オンライン薬局)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆